168 related articles for article (PubMed ID: 8226283)
1. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.
Miki K; Ichinose M; Ishikawa KB; Yahagi N; Matsushima M; Kakei N; Tsukada S; Kido M; Ishihama S; Shimizu Y
Jpn J Cancer Res; 1993 Oct; 84(10):1086-90. PubMed ID: 8226283
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
3. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
4. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
5. Serum pepsinogen and gastric cancer screening.
Mukoubayashi C; Yanaoka K; Ohata H; Arii K; Tamai H; Oka M; Ichinose M
Intern Med; 2007; 46(6):261-6. PubMed ID: 17379991
[TBL] [Abstract][Full Text] [Related]
6. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects.
Miki K; Ichinose M; Kawamura N; Matsushima M; Ahmad HB; Kimura M; Sano J; Tashiro T; Kakei N; Oka H
Jpn J Cancer Res; 1989 Feb; 80(2):111-4. PubMed ID: 2498245
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of gastric cancer screening using the serum pepsinogen test method.
Miki K; Morita M; Sasajima M; Hoshina R; Kanda E; Urita Y
Am J Gastroenterol; 2003 Apr; 98(4):735-9. PubMed ID: 12738449
[TBL] [Abstract][Full Text] [Related]
8. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
9. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
[TBL] [Abstract][Full Text] [Related]
10. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
Kikuchi S; Wada O; Miki K; Nakajima T; Nishi T; Kobayashi O; Inaba Y
Cancer; 1994 Jun; 73(11):2695-702. PubMed ID: 8194008
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.
Hattori Y; Tashiro H; Kawamoto T; Kodama Y
Jpn J Cancer Res; 1995 Dec; 86(12):1210-5. PubMed ID: 8636012
[TBL] [Abstract][Full Text] [Related]
13. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
14. Using serum pepsinogens wisely in a clinical practice.
Miki K; Urita Y
J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy.
Sipponen P; Samloff IM; Saukkonen M; Varis K
Gut; 1985 Nov; 26(11):1179-82. PubMed ID: 4065694
[TBL] [Abstract][Full Text] [Related]
16. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
17. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
[TBL] [Abstract][Full Text] [Related]
18. Serum pepsinogen in screening for gastric cancer.
Kodoi A; Yoshihara M; Sumii K; Haruma K; Kajiyama G
J Gastroenterol; 1995 Aug; 30(4):452-60. PubMed ID: 7550854
[TBL] [Abstract][Full Text] [Related]
19. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
20. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis.
Inoue M; Kobayashi S; Matsuura A; Hamajima N; Tajima K; Tominaga S
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):261-3. PubMed ID: 9521444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]